Who has invested in Recursion Pharmaceuticals?

Data Collective, Takeda, Bayer, NIH are named among the investors backing Recursion Pharmaceuticals.

Recursion Pharmaceuticals Funding: $900M Raised, IPO

Recursion Pharmaceuticals funding overview

Recursion Pharmaceuticals is a Biotech company based in Salt Lake City, UT. Recursion Pharmaceuticals has raised $900M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO. Investors on record include Data Collective, Takeda, Bayer, NIH. 4 distinct backers are named across the disclosed rounds.

Recursion Pharmaceuticals at a glance

Total raised: $900M
Latest round: IPO
Industry: Biotech
Headquarters: Salt Lake City, UT
Notable investors: Data Collective, Takeda, Bayer, NIH

Frequently asked about Recursion Pharmaceuticals funding

How much has Recursion Pharmaceuticals raised?: Recursion Pharmaceuticals has raised $900M in total disclosed funding across the rounds on record.
Who has invested in Recursion Pharmaceuticals?: Data Collective, Takeda, Bayer, NIH are named among the investors backing Recursion Pharmaceuticals.
What was the latest Recursion Pharmaceuticals funding round?: The most recent disclosed round is an IPO.
Where is Recursion Pharmaceuticals based?: Recursion Pharmaceuticals is based in Salt Lake City, UT.
What sector does Recursion Pharmaceuticals operate in?: Recursion Pharmaceuticals is tracked under Biotech from Salt Lake City, UT, with $900M in disclosed funding.

Recursion Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Salt Lake City below to benchmark round size and investor mix.

Recursion Pharmaceuticals Funding: $900M Raised, IPO

Recursion Pharmaceuticals funding overview

Recursion Pharmaceuticals at a glance

Frequently asked about Recursion Pharmaceuticals funding

Companies related to Recursion Pharmaceuticals (40)

Browse related funding lists (2)